New Oriental Education & Technology Group Inc.
New Oriental Education & Technology Group Inc. Q2 FY2026 earnings call
January 28, 2026 · fiscal period ended 2025-11
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-01-28
Management highlights
- Strong profit growth with non-GAAP operating margin up more than four percentage points. - Total net revenue grew 14.7% year over year to $1.19 billion. Non-GAAP operating income more than tripled to $89.1 million. Non-GAAP net income attributable to the company increased 6068.6% to $72.9 million. - Core business steady, new initiatives gaining traction. - Focus on operational efficiency and disciplined resource management. - Investments in new education initiatives, tourism, OMO, and AI. - EsterBio expanded product range and plans to scale vending machine model nationwide.
Segment performance
K-9 new educational business and high school tutoring: Accelerated year-over-year revenue growth, outpacing previous quarter. Overseas-related business: Overseas test prep business had 4% year-over-year revenue increase; overseas study consulting business had slight decrease of about 3% year-over-year. Adults and university students business: Recorded revenue increase. New education initiatives (non-academic tutoring, intelligent learning system/devices): Revenue grew 22% year over year this quarter. Non-dynamic two-front business rolled out to around 60 existing cities, with top 10 cities contributing over 60% of revenue. Intelligent learning system and device business launched in around 60 cities, top 10 cities contributing over 50% of this business. Integrated tourism-related business: Domestic and international study tours and research camp for K-12 and university students held in 55 cities, top 10 cities contributing over 50% of revenue. Newly launched tourism offering for middle-aged and senior citizens available in 30 key provinces, exploring health and wellness sector for seniors with over 30 partners in Hainan, Yunnan, and Guangxi. OMO system: $28.4 million invested during the quarter to upgrade and maintain platforms. AI: Refining and embedding AI across offerings, streamlining internal operations. East device (EsterBio): Private label SPUs reached 801, expanded product range to include seafood, healthcare products, etc., vending machine model profitable in select cities, plan to scale nationwide.
Guidance
- Total net revenue for the 2026 fiscal year (including EsterBio) expected to be in the range of $1.3132 billion to $1.3487 billion, representing a year-over-year increase of 11% to 14%. - Full fiscal year 2026 total net revenue guidance raised to $5.2923 billion to $5.4883 billion, representing a year-over-year increase of 8% to 12%. - Shareholder return plan: $0.12 per common share dividend, first installment paid, second installment to be announced. Share repurchase program: Repurchased approximately $86.3 million of ADS from the open market.
Risks
- Forward-looking statements involve inherent risks and uncertainties outlined in SEC filings. - Macroeconomic headwinds affecting overseas-related business. - Regulatory changes and their potential impact on operations.
Q&A highlights
Q: Felix Liu from UBS asked about segment growth breakdown and drivers of the lift in full-year guidance.
A: Stephen Yang discussed K-12 growth, overseas resilience, college business growth, and cost control.
Q: Alice Cai of Citibank inquired about business unit integration and margin impact.
A: Stephen Yang talked about merging overseas test prep and consulting businesses for better service and cost reduction.
Q: Lucy Yu from Bank of America Securities asked about margin expansion in Q2.
A: Stephen Yang mentioned margin expansion driven by better utilization, operating leverage, cost control, and EsterBio's profit contribution.
Q: Yikun Zheng from Citi asked about overseas business trends.
A: Stephen Yang noted overseas business resilience and market share gain, with flattish growth expected in the second half.
Q: D. S. Kim of JPMorgan asked about sustainable growth rate of new education business.
A: Stephen Yang discussed strategy shift to quality improvement, student retention, and expected sustainable growth.
Q: Timothy Zhao of Goldman Sachs asked about AI investment updates.
A: Stephen Yang mentioned AI helping new offerings, existing product improvement, and cost saving.
Q: Elsie Sheng from CLSA asked about marketing expense ratio and its relation to service efficiency.
A: Stephen Yang stated marketing expense ratio trend to continue down due to focus on product quality and internal customer service system.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.45 | $0.34 | +32.4% | $0.22 |
| Revenue | $1.19B | $1.37B | -12.7% | $1.04B |
Transcript
January 28, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.